Medpace Insider Trades
NASDAQ: MEDPHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 32 · $215.83M
- Shares bought / sold
- 0 / 353.28K
- Net activity
- Net selling $215.8 million
Medpace insider activity
Over the last 12 months, Medpace insiders reported 50 transactions on SEC Form 4: 0 open-market purchases and 32 sales. Insiders bought $0 and sold $215.8 million worth of stock, for net insider selling of $215.8 million. The largest seller was Troendle August J., with $190.9 million in reported sales.
The most recent filing shows McCarthy Cornelius P. III (Director) reporting a transaction in 28 shares on Sep 30, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put MEDP's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
MEDP insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 30, 2026 | Troendle August J.President & CEO | Sale | 21,966 | $13.74M | Form 4 |
| Sep 30, 2026 | Carley Brian TDirector | Option exercise | 36 | — | Form 4 |
| Sep 30, 2026 | Kraft Robert O.Director | Option exercise | 32 | — | Form 4 |
| Sep 30, 2026 | McCarthy Cornelius P. IIIDirector | Option exercise | 28 | — | Form 4 |
| Sep 29, 2026 | Troendle August J.President & CEO | Sale | 26,701 | $16.58M | Form 4 |
| Sep 28, 2026 | Troendle August J.President & CEO | Sale | 2,410 | $1.49M | Form 4 |
| Sep 25, 2026 | Troendle August J.President & CEO | Sale | 154 | $95.57K | Form 4 |
| Sep 24, 2026 | Troendle August J.President & CEO | Sale | 27,833 | $17.29M | Form 4 |
| Sep 23, 2026 | Troendle August J.President & CEO | Sale | 16,083 | $10.11M | Form 4 |
| Sep 22, 2026 | Troendle August J.President & CEO | Sale | 49,018 | $30.79M | Form 4 |
| Sep 21, 2026 | Troendle August J.President & CEO | Sale | 21,883 | $13.64M | Form 4 |
| Sep 17, 2026 | Troendle August J.President & CEO | Sale | 10,880 | $6.75M | Form 4 |
| Sep 16, 2026 | Troendle August J.President & CEO | Sale | 8,770 | $5.45M | Form 4 |
| Sep 15, 2026 | BURWIG SUSAN EExec. VP, Operations | Option exercise | 3,000 | $500.19K | Form 4 |
| Sep 15, 2026 | Troendle August J.President & CEO | Sale | 15,971 | $9.92M | Form 4 |
| Aug 27, 2026 | Troendle August J.President & CEO | Sale | 650 | $403.18K | Form 4 |
| Aug 26, 2026 | Troendle August J.President & CEO | Sale | 4,000 | $2.48M | Form 4 |
| Aug 26, 2026 | Kraft Robert O.Director | Sale | 3,858 | $2.38M | Form 4 |
| Aug 26, 2026 | Kraft Robert O.Director | Option exercise | 3,858 | $325.46K | Form 4 |
| Aug 25, 2026 | Troendle August J.President & CEO | Sale | 673 | $417.52K | Form 4 |
| Aug 24, 2026 | Troendle August J.President & CEO | Sale | 1,983 | $1.23M | Form 4 |
| Aug 21, 2026 | Troendle August J.President & CEO | Sale | 13,995 | $8.74M | Form 4 |
| Aug 20, 2026 | Troendle August J.President & CEO | Sale | 27,174 | $16.81M | Form 4 |
| Aug 20, 2026 | Brady Kevin M.CFO & Treasurer | Sale | 3,400 | $2.13M | Form 4 |
| Aug 20, 2026 | Brady Kevin M.CFO & Treasurer | Option exercise | 3,400 | $472.16K | Form 4 |
| Aug 19, 2026 | DAVENPORT FRED B JRDirector | Sale | 7,283 | $4.41M | Form 4 |
| Aug 19, 2026 | DAVENPORT FRED B JRDirector | Option exercise | 1,822 | $300.05K | Form 4 |
| Aug 19, 2026 | DAVENPORT FRED B JRDirector | Option exercise | 3,858 | $325.46K | Form 4 |
| Aug 19, 2026 | DAVENPORT FRED B JRDirector | Option exercise | 1,903 | $254.75K | Form 4 |
| Aug 19, 2026 | Troendle August J.President & CEO | Sale | 15,609 | $9.47M | Form 4 |
| Aug 19, 2026 | Carley Brian TDirector | Sale | 5,000 | $3.04M | Form 4 |
| Aug 13, 2026 | Troendle August J.President & CEO | Sale | 458 | $274.98K | Form 4 |
| Aug 12, 2026 | Troendle August J.President & CEO | Sale | 11,366 | $6.84M | Form 4 |
| Aug 11, 2026 | Troendle August J.President & CEO | Sale | 17,610 | $10.66M | Form 4 |
| Aug 11, 2026 | McCarthy Cornelius P. IIIDirector | Sale | 1,140 | $690.12K | Form 4 |
| Aug 10, 2026 | Troendle August J.President & CEO | Sale | 5,534 | $3.33M | Form 4 |
| Aug 7, 2026 | McCarthy Cornelius P. IIIDirector | Sale | 795 | $465.13K | Form 4 |
| Aug 7, 2026 | McCarthy Cornelius P. IIIDirector | Option exercise | 3,858 | $325.46K | Form 4 |
| Jul 28, 2026 | BURWIG SUSAN EExec. VP, Operations | Sale | 7,500 | $4.50M | Form 4 |
| Jul 28, 2026 | Troendle August J.President & CEO | Sale | 3,510 | $2.11M | Form 4 |
| Jul 27, 2026 | Troendle August J.President & CEO | Sale | 3,728 | $2.24M | Form 4 |
| Jun 30, 2026 | Carley Brian TDirector | Option exercise | 36 | — | Form 4 |
| Jun 30, 2026 | Kraft Robert O.Director | Option exercise | 33 | — | Form 4 |
| Jun 30, 2026 | McCarthy Cornelius P. IIIDirector | Option exercise | 28 | — | Form 4 |
| May 28, 2026 | EWALD STEPHEN PGeneral Counsel & Corp. Secy. | Sale | 16,349 | $7.36M | Form 4 |
| May 28, 2026 | EWALD STEPHEN PGeneral Counsel & Corp. Secy. | Option exercise | 16,349 | $2.27M | Form 4 |
| Apr 24, 2026 | Brady Kevin M.CFO & Treasurer | Option exercise | 7,000 | $972.09K | Form 4 |
| Apr 24, 2026 | EWALD STEPHEN PGeneral Counsel & Corp. Secy. | Option exercise | 3,500 | $486.05K | Form 4 |
| Mar 31, 2026 | Kraft Robert O.Director | Option exercise | 33 | — | Form 4 |
| Mar 31, 2026 | McCarthy Cornelius P. IIIDirector | Option exercise | 29 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4